# Automated Quality Controlled Analysis of 2D Phase Contrast Cardiovascular Magnetic Resonance Imaging

arXiv: https://arxiv.org/abs/2209.14212 · HTML: https://mlsanity.com/paper/2209.14212/

## Key facts

- Cited by 1 papers in the map (data through 14 Oct 2026).
- Builds on 4 of its 19 references that are in the map.
- First posted on arXiv 28 Sep 2022.

## Builds on (most cited first, 4 of 4)

- [Very Deep Convolutional Networks for Large-Scale Image Recognition](https://mlsanity.com/paper/1409.1556/) (2014)
- [Automatic CNN-based detection of cardiac MR motion artefacts using k-space data augmentation and curriculum learning](https://mlsanity.com/paper/1810.12185/) (2018)
- [Deep Generative Model-based Quality Control for Cardiac MRI Segmentation](https://mlsanity.com/paper/2006.13379/) (2020)
- [Learning-Based Quality Control for Cardiac MR Images](https://mlsanity.com/paper/1803.09354/) (2018)

## Built on by (most cited first, 1 of 1)

- [Improving Deep Learning Model Calibration for Cardiac Applications using Deterministic Uncertainty Networks and Uncertainty-aware Training](https://mlsanity.com/paper/2405.06487/) (2024)

## Abstract (arXiv)

Flow analysis carried out using phase contrast cardiac magnetic resonance imaging (PC-CMR) enables the quantification of important parameters that are used in the assessment of cardiovascular function. An essential part of this analysis is the identification of the correct CMR views and quality control (QC) to detect artefacts that could affect the flow quantification. We propose a novel deep learning based framework for the fully-automated analysis of flow from full CMR scans that first carries out these view selection and QC steps using two sequential convolutional neural networks, followed by automatic aorta and pulmonary artery segmentation to enable the quantification of key flow parameters. Accuracy values of 0.958 and 0.914 were obtained for view classification and QC, respectively. For segmentation, Dice scores were >0.969 and the Bland-Altman plots indicated excellent agreement between manual and automatic peak flow values. In addition, we tested our pipeline on an external validation data set, with results indicating good robustness of the pipeline. This work was carried out using multivendor clinical data consisting of 986 cases, indicating the potential for the use of this pipeline in a clinical setting.